CMN Audio
Nasal Spray Sends CRISPR to the Brain

By: Gorm Palmgren - Mar. 28, 2022

Most pharmaceuticals don't reach the brain, leaving cognitive impairments due to diseases like mucopolysaccharidoses (MPS) hard to treat. Now, a Brazilian research team has developed a method for nasal delivery of CRISPR reagents to the brain that improves MPS cognitive symptoms in mice. Experiments will proceed with monkeys later this year.

Listen to this article
Clinical Update: News on Two Cancer Gene Editing Trials

By: Karen O'Hanlon Cohrt - Mar. 24, 2022

This week's update features Iovance Biotherapeutics' new cancer immunotherapy candidate IOV-4001 that was recently cleared for clinical trial initiation in the U.S. In additional news, the first patient has been dosed in Wugen's WU-CART-007 trial for certain blood cancers.

Listen to this article
Using CRISPR-Cas9 to “Attack” Cancer Cells: A New Avenue for Personalised Cancer Treatment?

By: Christos Evangelou - Mar. 21, 2022

Researchers at Ulsan National Institute of Science and Technology in South Korea have developed a CRISPR-Cas9-based method to eliminate tumour cells. In this first proof-of-concept study, they confirm the feasibility of using CRISPR-Cas9 to selectively kill cancer cells in various disease models by targeting cancer-specific InDels.

Listen to this article
close
Search CRISPR Medicine